Paul K. Wotton
2013
In 2013, Paul K. Wotton earned a total compensation of $2M as Former Chief Executive Officer at Antares Pharma, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $308,000 |
|---|---|
| Option Awards | $366,551 |
| Salary | $540,705 |
| Stock Awards | $783,336 |
| Other | $10,064 |
| Total | $2,008,656 |
Wotton received $783.3K in stock awards, accounting for 39% of the total pay in 2013.
Wotton also received $308K in non-equity incentive plan, $366.6K in option awards, $540.7K in salary and $10.1K in other compensation.
Rankings
In 2013, Paul K. Wotton's compensation ranked 3,883rd out of 12,286 executives tracked by ExecPay. In other words, Wotton earned more than 68.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,883 out of 12,286 | 68th |
Division Manufacturing | 1,316 out of 4,612 | 72nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 174 out of 681 | 74th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 104 out of 420 | 75th |
Industry Surgical and Medical Instruments and Apparatus | 55 out of 263 | 79th |
Source: SEC filing on April 15, 2015.
Wotton's colleagues
We found two more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2013.